Revenue Recognition (Tables)

6 Months Ended

Jul. 01, 2023

Revenue from Contract with Customer [Abstract]

Summary of Disaggregation of Revenue

The following is a summary of our net sales by category(1) (in millions):

	Three Months Ended				Six Months Ended
	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
CSCA
Nutrition	$	164.8	$	125.1	$	304.7	$	252.3
Upper Respiratory	137.7		145.9		292.0		298.7
Digestive Health	126.7		125.1		250.9		243.7
Pain and Sleep-Aids	97.4		102.6		200.9		205.5
Oral Care	76.9		76.6		161.3		147.0
Healthy Lifestyle	67.3		67.3		140.7		134.9
Skin Care	50.8		48.6		103.1		89.5
Women's Health	12.5		12.0		24.4		20.2
Vitamins, Minerals, and Supplements ("VMS")	4.4		8.2		8.4		15.9
Other CSCA(2)	12.3		16.6		28.0		30.3
Total CSCA	$	750.8	$	728.0	$	1,514.4	$	1,438.0
CSCI
Skin Care	$	123.0	$	102.5	$	206.4	$	176.4
Upper Respiratory	64.9		58.8		149.7		125.3
Healthy Lifestyle	60.6		59.1		127.0		118.0
Pain and Sleep-Aids	52.8		49.1		102.7		103.1
VMS	41.5		42.3		89.3		91.8
Women's Health	31.9		23.3		61.0		37.0
Oral Care	21.6		20.6		50.7		49.5
Digestive Health	10.4		10.0		19.2		19.2
Other CSCI(3)	35.7		28.0		54.4		37.9
Total CSCI	442.4		393.7		860.4		758.2
Total net sales	$	1,193.1	$	1,121.7	$	2,374.8	$	2,196.2

(1) We updated our global reporting product categories as a result of our product portfolio reconfiguration. These product categories have been adjusted retroactively to reflect the changes and have no impact on historical financial position, results of operations, or cash flows.

(2) Consists primarily of product sales and royalty income related to supply and distribution agreements and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.

(3) Consists primarily of our rare diseases business and other miscellaneous or otherwise uncategorized product lines, none of which is greater

than 10% of the segment net sales.

We generated net sales in the following geographic locations(1) (in millions):

	Three Months Ended				Six Months Ended
	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
U.S.	$	735.8	$	717.6	$	1,486.0	$	1,400.6
Europe(2)	425.7		381.9		832.8		733.6
All other countries(3)	31.6		22.2		56.0		62.0
Total net sales	$	1,193.1	$	1,121.7	$	2,374.8	$	2,196.2

(1) The net sales by geography are derived from the location of the entity that sells to a third party.

(2) Includes Ireland net sales of $11.9 million and $19.1 million for the three and six months ended July 1, 2023, respectively, and $7.3 million and $13.9 million for the three and six months ended July 2, 2022, respectively.

(3) Includes net sales generated primarily in Australia and Canada.

Summary of Contract with Customer Balances

The following table provides information about contract assets from contracts with customers (in millions):

	Balance Sheet Location	July 1, 2023		December 31, 2022
Short-term contract assets	Prepaid expenses and other current assets	$	25.8	$	41.5